Basket | Login

 
 
 
 

Clinical trials by country

Phase II trials

Belgium

  1. AUTONOMY (planned)
  2. GRADUATION

Czech Republic

  1. ALZ-801
  2. T-817MA

Denmark

  1. VIVIAD

Germany

  1. GRADUATION
  2. T-817MA
  3. VIVIAD

Finland

  1. ACI-24-1801
  2. ACI-35-1802

France

  1. AUTONOMY (planned)
  2. GRADUATION (planned)

Hungary

  1. T-817MA

Ireland

  1. T-817MA

Netherlands

  1. ACI-35-1802
  2. ALZ-801
  3. AUTONOMY (planned)
  4. T-817MA
  5. TRAILBLAZER-ALZ 2 
  6. VIVIAD

Italy

  1. GRADUATION (planned)

Poland

  1. ACI-24-1801 (planned)
  2. Brainshuttle AD (planned)
  3. GRADUATION
  4. TRAILBLAZER-ALZ 2

Spain 

  1. AUTONOMY
  2. Brainshuttle AD
  3. GRADUATION (planned)
  4. T-817MA

Sweden

  1. ACI-24-1801
  2. ACO-35-1802 (planned)
  3. AUTONOMY (planned)

UK

  1. ACI-24-1801
  2. ACI-35.1802 
  3. AUTONOMY (planned)
  4. DESPIAD
  5. GRADUATION
  6. T-817MA

 

 
 

Last Updated: Wednesday 14 April 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options